Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-18 | Atara Biotherapeutics, Inc. | Henrich Jill
(EVP, Chief Regulatory Officer) |
S | Common Stock | D | 1000 | $11.20 - $11.20 | $11,198 |
2024-11-18 | Atara Biotherapeutics, Inc. | Hyllengren Eric J
(EVP, CFO and COO) |
S | Common Stock | D | 1364 | $11.20 - $11.20 | $15,274 |
2024-11-18 | Atara Biotherapeutics, Inc. | Nguyen AnhCo
(President and CEO) |
S | Common Stock | D | 1664 | $11.20 - $11.20 | $18,633 |
2024-09-09 | Atara Biotherapeutics, Inc. | Nguyen AnhCo
(President and CEO) |
A | Common Stock | A | 45000 | $0.00 - $0.00 | $0 |
2024-08-16 | Atara Biotherapeutics, Inc. | Touchon Pascal
(President and CEO) |
S | Common Stock | D | 3038 | $6.63 - $6.63 | $20,138 |
2024-08-16 | Atara Biotherapeutics, Inc. | Nguyen AnhCo
(EVP, Chief Sci. & Tech Officer) |
S | Common Stock | D | 1821 | $6.63 - $6.63 | $12,071 |
2024-08-16 | Atara Biotherapeutics, Inc. | Murugan Amar
(EVP, Chief Legal Officer) |
S | Common Stock | D | 1158 | $6.63 - $6.63 | $7,675 |
2024-08-16 | Atara Biotherapeutics, Inc. | Hyllengren Eric J
(EVP, CFO) |
S | Common Stock | D | 1070 | $6.63 - $6.63 | $7,092 |
2024-08-16 | Atara Biotherapeutics, Inc. | Henrich Jill
(EVP, Global Head RA & Quality) |
S | Common Stock | D | 963 | $6.63 - $6.63 | $6,383 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |